Figà-Talamanca L, Gualandi C, Di Meo L, Di Battista G, Neri G, Lo Russo F
Neurology. 1985 Feb;35(2):258-61. doi: 10.1212/wnl.35.2.258.
Hyperthermia, with no signs of any underlying infection, may occur in the course of neuroleptic malignant syndrome, fatal catatonia, heat stroke, or malignant hyperthermia. We describe hyperthermia as a complication after discontinuance of antiparkinsonian treatment with levodopa/carbidopa and bromocriptine. Impaired nigrostriatal, hypothalamic, and mesolimbic dopaminergic functions could be involved in pathogenesis.
